Atlas Trials

W0265-103: A Single-Center, Evaluator-Blinded, Randomized, Placebo Controlled, Phase 1 Clinical Trial Evaluating The Phototoxic Potential Of Topically Applied Clindamycin 1.0% - Tretinoin 0.025% Gel (Ct Gel) In Healthy Volunteers

Clinical trial NCT01929278 · COMPLETED

Trial details

NCT number
NCT01929278
Sponsor
Stiefel, a GSK Company
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Acne Vulgaris
Start date
2008-12-08
Primary completion
2008-12-19
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.